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Augmented ST-Segment Elevation
During Recovery From Exercise Predicts
Cardiac Events in Patients With Brugada Syndrome
Hisaki Makimoto, MD,* Eiichiro Nakagawa, MD, PHD,† Hiroshi Takaki, MD, PHD,*
Yuko Yamada MD,* Hideo Okamura, MD,* Takashi Noda, MD, PHD,* Kazuhiro Satomi, MD, PHD,*
Kazuhiro Suyama, MD, PHD,* Naohiko Aihara, MD,* Takashi Kurita, MD, PHD,‡
Shiro Kamakura, MD, PHD,* Wataru Shimizu, MD, PHD*
Suita and Osaka, Japan
Objectives The goal of this study was to evaluate the prevalence and the clinical significance of ST-segment elevation
during recovery from exercise testing.
Background During recovery from exercise testing, ST-segment elevation is reported in some patients with Brugada
syndrome (BrS).
Methods Treadmill exercise testing was conducted for 93 patients (91 men), 46  14 years of age, with BrS (22 docu-
mented ventricular fibrillation, 35 syncope alone, and 36 asymptomatic); and for 102 healthy control subjects
(97 men), 46  17 years of age. Patients were routinely followed up. The clinical end point was defined as the
occurrence of sudden cardiac death, ventricular fibrillation, or sustained ventricular tachyarrhythmia.
Results Augmentation of ST-segment elevation 0.05 mV in V1 to V3 leads compared with baseline was observed at
early recovery (1 to 4 min at recovery) in 34 BrS patients (37% [group 1]), but was not observed in the remain-
ing 59 BrS patients (63% [group 2]) or in the 102 control subjects. During 76  38 months of follow-up, ventric-
ular fibrillation occurred more frequently in group 1 (15 of 34, 44%) than in group 2 (10 of 59, 17%; p  0.004).
Multivariate Cox regression analysis showed that in addition to previous episodes of ventricular fibrillation (p 
0.005), augmentation of ST-segment elevation at early recovery was a significant and independent predictor for
cardiac events (p  0.007), especially among patients with history of syncope alone (6 of 12 [50%] in group 1
vs. 3 of 23 [13%] in group 2) and among asymptomatic patients (3 of 15 [20%] in group 1 vs. 0 of 21 [0%] in
group 2).
Conclusions Augmentation of ST-segment elevation during recovery from exercise testing was specific in patients with BrS,
and can be a predictor of poor prognosis, especially for patients with syncope alone and for asymptomatic
patients. (J Am Coll Cardiol 2010;56:1576–84) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.06.033i
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orugada syndrome (BrS) is recognized as a clinical syn-
rome that leads to sudden cardiac death (SCD) in middle-
ged persons due to ventricular fibrillation (VF) (1).
rugada syndrome is defined by a distinct 12-lead electro-
ardiogram (ECG) pattern in precordial leads (V1 to V3)
resenting coved-type ST-segment elevation. Both depolar-
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ealth, Labor and Welfare, Japan. All other authors have reported that they have no
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Manuscript received April 21, 2010; revised manuscript received June 8, 2010,
ccepted June 15, 2010.zation and repolarization hypotheses have been reported for
he pathogenesis of phenotype in BrS (2–5). Although
everal indexes have been reported as predictive factors of
F occurrence (6), the recent largest series of BrS patients
uggested that there were no reliable predictors of cardiac
vents except for prior symptoms and spontaneous type 1
CG (7). However, risk stratification remains disputable,
specially for BrS patients without documented VF
pisodes.
See page 1585
Autonomic function has been suggested to relate to the
ccurrence of VF in BrS. It has also been shown that
T-segment elevation in patients with BrS was augmented
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November 2, 2010:1576–84 Exercise Test in Brugada Syndromey selective stimulation of muscarinic receptors but miti-
ated by beta-adrenergic stimulation (8). Heart rate during
xercise testing is considered as 1 parameter to evaluate
ardiac autonomic function (9). Sympathetic withdrawal
nd parasympathetic activation occur at early recovery after
xercise (10), which are expected to augment ST-segment
levation directly by inhibition of calcium-channel current
r by decreasing heart rate (5,11). Two cases of BrS were
eported in which ST-segment was augmented during and
fter exercise (12). Amin et al. (13) recently assessed the
CG responses to exercise in BrS patients with and without
CN5A mutations and control subjects. They reported that
xercise resulted in an increase of peak J-point amplitude in
ll groups, including control subjects, and more QRS
idening in BrS patients with SCN5A mutation. The peak
-point amplitude measured by Amin et al. (13) is thought
o represent the depolarization parameter as QRS duration,
r at least the combined parameter of both depolarization
nd repolarization. Therefore, in the present study, we
easured several points of ST-segment as a repolarization
arameter rather than a depolarization parameter, and tried
o investigate the relationship between augmented ST-
egment elevation during recovery from exercise testing and
rognosis of BrS patients. We also evaluated parasympa-
hetic reactivation by using heart rate recovery (HRR),
hich is defined as heart rate decay in the first minute after
xercise cessation, and its relation with ST-segment change.
ethods
tudy population. The study population consisted of 93
onsecutive Japanese patients with BrS (91 males; mean age
6  14 years) admitted to the National Cerebral and
ardiovascular Center in Suita, Japan, between 1994 and
006. Ventricular fibrillation was documented in 22 BrS
atients, syncope alone in 35 patients, and the remaining 36
atients were asymptomatic. As control subjects, 102 age-,
ex-, and QRS duration-matched healthy subjects were
andomly selected from persons who underwent treadmill
xercise testing between 2002 and 2007 (97 males; mean age
6  17 years). They included 55 normal subjects with
ormal QRS duration (100 ms), 21 with incomplete right
undle branch block (RBBB) (100 ms QRS duration
120 ms), and 26 with complete RBBB (120 ms QRS
uration) but without structural heart disease or any ven-
ricular arrhythmias.
Brugada syndrome was diagnosed when a coved ST-
egment elevation (0.2 mV at J-point) was observed in1 of
he right precordial leads (V1 to V3) in the presence or absence
f a sodium-channel–blocking agent, and in conjugation with
of the following: documented VF, polymorphic ventricular
achycardia, family history of SCD 45 years of age, family
istory of BrS, inducibility of VF with programmed electrical
timulation, syncope, or an nocturnal agonal respiration (6).
tructural heart diseases were carefully excluded by history making, physical examinations,
hest roentgenogram, ECG, and
chocardiogram.
linical, laboratory, electrocar-
iographic, and electrophysi-
logic study. The following clin-
cal data were collected: family
istory of SCD (45 years of age)
r BrS, documented atrial fibrilla-
ion (AF), documented VF, syn-
ope, age at the first cardiac event,
nd implantation of implantable
ardioverter-defibrillator (ICD).
A 12-lead ECG was recorded
n all 93 BrS patients, and RR
nterval, PR interval (lead II),
RS duration (lead V5), cor-
ected QT interval (lead V2),
RS axis, J-point amplitude
leads V2), and amplitude of several points of ST-segment
leads V1, V2, V3) were measured.
Signal-averaged ECG was recorded and analyzed in
1 patients by using a signal-averaged ECG system
1200EPX, Arrhythmia Research Technology, Milwaukee,
isconsin). Three parameters were assessed using a com-
uter algorithm: 1) total filtered QRS duration; 2) root
ean square voltage of the terminal 40 ms of the filtered
RS complexes (V40); and 3) duration of low-amplitude
ignals 40 V of the filtered QRS complexes (T40). Late
otential was considered present when the 2 criteria (V40
18 V and T40 38 ms) were fulfilled.
Electrophysiologic study (EPS) was performed in 79 BrS
atients (21 documented VF patients, 30 syncope alone
atients, and 28 asymptomatic patients). A maximum of 3
rogrammed ventricular extrastimuli were delivered from
he right ventricular apex and RVOT, unless VF was
nduced. No patients received antiarrhythmic drugs before
PS. The atrio-His and His-ventricular intervals were
easured during sinus rhythm. The EPS was conducted
fter all subjects gave written informed consent.
Genetic testing for the presence of an SCN5A mutation
as also conducted.
xercise testing. Treadmill exercise testing was conducted
n all 93 patients with BrS and 102 control subjects. Neither
rS patients nor control subjects used antiarrhythmic
gents. A symptom-limited or submaximal (up to 90% of
he age-predicted maximum heart rate) graded treadmill
xercise testing similar to modified Bruce protocol was used.
ll 93 BrS patients and 102 control subjects were in normal
inus rhythm, and none had atrioventricular block at the
xercise testing. The standard 12-lead ECGs were recorded
t rest, at the end of each exercise stage, at peak exercise, and
t every minute during recovery. The amplitude of ST-
egment from the isoelectric line at the right precordial leads
V1 to V3 leads) and QRS width at V5 lead were manually
Abbreviations
and Acronyms
AF  atrial fibrillation
BrS  Brugada syndrome
ECG  electrocardiogram
EPS  electrophysiologic
study
HRR  heart rate recovery
ICD  implantable
cardioverter-defibrillator
RBBB  right bundle
branch block
RVOT  right ventricular
outflow tract
SCD  sudden cardiac
death
VF  ventricular fibrillationeasured. The ST-segment point was defined as the point
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Exercise Test in Brugada Syndrome November 2, 2010:1576–84here the vertical line from the end point of QRS at V5 lead
ntersected the precordial leads. We also measured peak
-point amplitude in lead V2 as a depolarization parameter,
nd amplitude of the point, which was 40 and 80 ms later
han the peak J-points (ST40, ST80) in lead V2 as a
epolarization parameter. Measurements of ECG parame-
ers were performed as the mean of 3 beats by single
lectrocardiologist who knew nothing about the patients.
ignificant augmentation of ST-segment elevation was
efined as ST-segment amplitude increase 0.05 mV in at
east 1 of V1 to V3 leads at early recovery (1 to 4 min at
ecovery) compared with the ST-segment amplitude at
aseline (pre-exercise). We also recorded heart rate and
lood pressure during exercise testing.
The HRR was defined as decay of heart rate from peak
xercise to 1 min at recovery.
ollow-up. Follow-up was started after undergoing tread-
ill exercise testing. All patients with BrS were routinely
ollowed up at the outpatient clinic of our hospital. The
CD implantation was performed in 63 BrS patients (20
ocumented VF patients, 25 syncope alone patients, and 18
symptomatic patients). Antiarrhythmic drugs were pre-
cribed for 7 patients; 2 patients who had episodes of VF but
efused implantation of ICD (disopyramide 300 mg daily
or 1 patient, and amiodarone 200 mg daily for another
atient), 2 patients who had AF (quinidine 300 mg daily),
nd 3 patients who had previous history of both VF and AF
nd implanted ICD (quinidine 300 mg daily for 1 patient,
miodarone 200 mg daily for 2 patients).
Cardiac events were defined as SCD or aborted cardiac
rrest, and VF or sustained ventricular tachyarrhythmia
ocumented by ICD or ECG recordings.
tatistical analysis. Data were analyzed with Dr. SPSS II
or Windows software package (SPSS Inc., Chicago, Illi-
ois). Numeric values are expressed as mean  SD. The
hi-square test, Student t test, or 1-way analysis of variance
as performed when appropriate to test for statistical
ifferences. All p values 0.05 were considered statistically
ignificant. Event rate curves were plotted according to the
aplan-Meier method, and were analyzed with the log-rank
est. Univariate and multivariate Cox regression were per-
ormed to assess whether 7 indexes can be significant and
ndependent predictors of subsequent cardiac events. We
sed the forward step-wise approach with p to enter a value
f 0.05 for multivariate analysis. Augmentation of ST-
egment elevation at early recovery, family history of SCD
r BrS, spontaneous coved-type ST-segment elevation,
resence of SCN5A mutation, late potential, VF inducibility
uring EPS, and previous episodes of VF were included as
ndexes.
esults
here were no significant differences between 93 BrS
atients and 102 control subjects with respect to age at (xercise testing, sex, QRS duration (lead V5), and QTc
nterval (lead V2), as summarized in Table 1. The RR
nterval and PR interval (lead II) were significantly longer in
rS patients than in control subjects.
esponse of ST-segment elevation during treadmill exercise
esting. Among 93 BrS patients, significant augmentation
f ST-segment elevation mostly associated with coved
attern at early recovery phase was observed in 34 BrS
atients (37% [group 1]), but not in the remaining 59 BrS
atients (63% [group 2]). Conversely, ST-segment augmen-
ation was never observed in any of the 102 control subjects
34 of 93 [37%] vs. 0 of 102 [0%], p  0.0001). Typical
esponses of ST-segment amplitudes of 3 groups are shown
n Figure 1. Composite data of serial changes of ST-
egment amplitude in V1 and V2 leads during exercise
esting are illustrated in Figure 2A. The serial changes of
T-segment amplitude in V3 lead showed the same trend
not shown). In group 1, ST-segment amplitude decreased
t peak exercise and started to reascend at early recovery,
nd culminated at 3 min of recovery (Figs. 1A and 2A). In
ontrast, ST-segment amplitude of group 2 patients and
ontrol subjects decreased at peak exercise, and gradually
eturned to the baseline amplitude rather than showing
ugmentation (Figs. 1B to 1D and 2A). Significant differ-
nces were identified between group 1 and group 2 patients
n the ST-segment amplitude in leads V1 and V2 from peak
xercise to 6 min of recovery, whereas no major differences
ere observed between group 2 patients and control subjects
Fig. 2A). Composite data of serial changes of peak J-point
mplitude, ST40, and ST80 amplitudes are presented in
igure 2B. The peak J-point amplitude and ST40 amplitude
uring recovery showed the same trend as the ST-segment
mplitude in Figure 2A. Significant differences were iden-
ified between group 1 and group 2 patients in the peak
-point and ST40 amplitudes from peak exercise to 6 min of
ecovery. The ST80 amplitude showed significant differ-
nces between group 1 and group 2 patients at 2, 3, and 4
in of recovery. At peak exercise, the peak J-point ampli-
ude increased in 34 (37%) of 93 Brugada patients and in 26
nitial Characteristics ofa ents nd Control SubjectsTable 1 Initial Characteri tics ofPatients and Control Subjects
Brugada Patients
(n  93)
Control Subjects
(n  102) p Value
Age at exercise testing, yrs 46 14 46 17 NS
Sex, male 91 (98%) 97 (95%) NS
Electrocardiographic
characteristics, ms
RR 952 151 903 140 0.020
PR 178 30 165 24 0.001
QRS duration 98 16 98 20 NS
QTc 416 44 406 30 NS
alues are mean  SD or n (%).
QTc  corrected QT interval.26%) of 102 control subjects, although the ST-segment
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November 2, 2010:1576–84 Exercise Test in Brugada Syndromemplitude and ST40 amplitude decreased in most patients
f both groups.
Comparison of HRR is shown in Figure 3. The HRR of
roup 1 patients was significantly larger than that of group
patients (32  15 vs. 23  10, p  0.0007) and control
ubjects (32  15 vs. 26  10, p  0.021). The differences
f HRR between group 2 patients and control subjects were
lso statistically significant (23  10 vs. 26  10, p 
.026).
Although there were no sustained or nonsustained ven-
ricular arrhythmias throughout exercise testing, single pre-
ature ventricular complexes were observed during exercise
n 8 of the group 1 patients and in 11 of the group 2
atients, and at recovery in 10 of the group 1 patients and in
of the group 2 patients. There were no significant
ifferences between groups 1 and 2 in incidences of prema-
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Figure 1 Typical Responses of ST-Segment Amplitude in Leads
During Exercise Testing in Brugada Syndrome Patient
(A) In the group 1 Brugada patient showing saddle-back type ST-segment (lead V2
scended at early recovery (3 min), resulting in typical coved-type ST-segment eleva
amplitude decreased at peak exercise and gradually recovered to the baseline at
despite not showing ST-segment augmentation in A and C. The ST-segment amplit
indicates the line from the end point of the QRS interval at electrocardiography leaure ventricular complexes. wlinical, laboratory, electrocardiographic, and electro-
hysiologic characteristics. Comparison of the clinical,
aboratory, electrocardiographic, and electrophysiologic
haracteristics between groups 1 and 2 patients are shown in
able 2. There were no significant differences in these
haracteristics between groups 1 and 2 except for the
resence of SCN5A mutation and late potential (SCN5A
utation, 17% vs. 5%, p  0.048; late potential, 82% vs.
3%, p  0.004).
ollow-up. The mean follow-up period for the 93 BrS
atients was 75.7  38.4 months. During follow-up, 25 of
ll 93 BrS patients (27%) had cardiac events, and the
ncidence of cardiac events was significantly higher in group
than in group 2 patients (44% vs. 17%, p  0.004). The
eriod from exercise testing to cardiac events ranged from 1
o 78 months (median 12 months). One patient in group 2,
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seline, ST-segment amplitude slightly decreased at peak exercise, but rea-
B, C) In the group 2 Brugada patient and (D) in the control subject, ST-segment
ry. It is noteworthy that the peak J-point amplitude in lead V2 was augmented
re shown as numeric values expressed in millivolts (mV). The red vertical lineV1
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Exercise Test in Brugada Syndrome November 2, 2010:1576–84mide 300 mg daily, died of VF. Three of 7 patients with
edication had cardiac events, including 1 death.
redictors of outcome. Kaplan-Meier analysis demon-
trated significant differences in the time to the first cardiac
vent depending on the presence of ST-segment augmentation
Figure 2 Composite Data of Serial Changes of ST-Segment Am
(A) Composite data of serial changes of ST-segment amplitude in lead V1 (left) an
(squares) and group 2 Brugada syndrome patients (triangles), and in control subj
amplitude (right) in lead V2. The ST-segment amplitude decreased at peak exercis
group 1 Brugada patients. In the group 2 Brugada patients and control subjects, t
baseline level during recovery. The peak J-point amplitude and ST40 amplitude du
tude was influenced by T wave, especially at rapid heart rate, the trends of the 3 g
ST-segment amplitudes are shown as values compared to pre-exercise ST-segmenuring recovery from exercise (Fig. 4A). Group 1 patients had Ssignificantly higher cardiac event rate than group 2 patients
log-rank, p  0.0029). Previous history of VF (Fig. 4B) and
ositive SCN5A mutation (Fig. 4C) also had significant values
or occurrence of subsequent cardiac events (p  0.0013 and
 0.028, respectively); however, spontaneous coved-type
e
V2 (right) during exercise (Ex.) testing in group 1 Brugada syndrome patients
ircles). (B) Peak J-point amplitude (left), ST40 amplitude (middle), and ST80
started to reascend at early recovery, and culminated at 3 min of recovery in
segment amplitude decreased at peak exercise and gradually recovered to the
covery showed the same trend as the ST-segment amplitude. Since ST80 ampli-
were somewhat different from ST-segment amplitude or ST40 amplitude. The
itudes. p  0.05.plitud
d lead
ects (c
e and
he ST-
ring re
roups
t amplT-segment elevation did not predict cardiac events (p 
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November 2, 2010:1576–84 Exercise Test in Brugada Syndrome.068) (Fig. 4D). The results of Cox regression analysis are
hown in Table 3. In univariate analysis, indexes predictive of
ardiac events were previous episodes of VF (p  0.003),
T-segment augmentation at early recovery (group 1; p 
.005), and presence of SCN5A mutation (p  0.037). In
ultivariate Cox regression analysis, previous episodes of VF
nd ST-segment augmentation at early recovery were signifi-
ant and independent predictors of subsequent cardiac events
p  0.005 and p  0.007, respectively).
The incidence of cardiac events during follow-up in the
ubgroups according to symptoms before exercise testing is
hown in Table 4. In the subgroup of 35 BrS patients with
yncope alone, group 1 had a significantly higher cardiac
vent rate than group 2 (log-rank, 6 of 12 [50%] vs. 3 of 23
13%], p  0.016). Of note, among 36 asymptomatic
atients, only 3 patients (9%) in group 1 experienced cardiac
vents. The log-rank test also demonstrated higher cardiac
vent risk in group 1 compared with group 2 (3 of 15 [20%]
s. 0 of 21 [0%], p  0.039).
iscussion
he major findings of the present study were the following:
) 37% of BrS patients showed ST-segment augmentation
t early recovery during exercise testing; 2) ST-segment
ugmentation at early recovery was specific in BrS patients,
nd was significantly associated with a higher cardiac event
ate, notably for patients with previous episode of syncope or
or asymptomatic patients; and 3) BrS patients with ST-
Figure 3 Comparison of HRR After Exercise Cessation
Comparison of heart rate recovery (HRR) 1 min after exercise cessation among
Brugada syndrome patients of groups 1 and 2 and control subjects. The HRR
in group 1 patients was significantly larger than that in group 2 (32  15
beats/min vs. 23  10 beats/min, p  0.0007) and in control subjects (32 
15 beats/min vs. 26  10 beats/min, p  0.021). The differences of HRR
between group 2 patients and control subjects were also significant (23  10
beats/min vs. 26  10 beats/min, p  0.026).egment augmentation at early recovery showed signifi- wantly larger HRR. This is the first systematic report on the
elationship between ST-segment augmentation during re-
overy from exercise and prognosis for BrS patients.
ugmentation of ST-segment elevation and possible
echanism. It is well known that autonomic function influ-
nces an extent of ST-segment elevation in BrS (8). The
T-segment elevation is mitigated by administration of
-adrenergic agonists and is enhanced by parasympathetic
gonists such as acetylcholine in experimental and clinical
nvestigations (5,14–16). Parasympathetic reactivation is
hought to occur at early recovery after treadmill exercise
esting, especially in the first minute after cessation of exercise
10,17). In the present study, we measured the ST-segment
mplitude as a repolarization parameter rather than a depolar-
zation parameter, and evaluated HRR to investigate the
orrelation between ST-segment augmentation and parasym-
athetic activity (9,18). The BrS patients who had ST-segment
ugmentation had significantly larger HRR compared with
atients who did not, suggesting that the ST-segment aug-
entation was closely related to higher parasympathetic activ-
ty. However, it is still unclear whether ST-segment augmen-
ation observed in the 34 BrS patients was simply due to more
ncreased parasympathetic activity or to more increased suscep-
ibility (hypersensitivity) to the parasympathetic reactivation.
Conversely, the SCN5A mutation was more frequently
dentified in group 1. Scornik et al. (19) reported that SCN5A
utation can accentuate parasympathetic activity toward the
eart directly. It was also reported that specific mutations in the
CN5A gene may lead to augmentation of J-point amplitude
r ST-segment amplitude during beta-adrenergic stimulation
20,21). Veldkamp et al. (20) demonstrated that a specific
CN5A mutation, 1795insD, augments slow inactivation, and
elays recovery of sodium channel availability, thus reducing
he sodium current and resulting in augmented peak J-point
mplitude at rapid heart rate. Increased body temperature
nduced by exercise can be a risk of life-threatening arrhyth-
ias in patients with BrS (22). A specific SCN5A missense
utation, T1620M, was reported to cause a faster decay of the
odium channel but slower recovery from inactivation, result-
ng in increased ST-segment elevation in precordial leads at
igher temperatures during exercise. Although Amin et al. (13)
eported that exercise induced augmentation of peak J-point
mplitude, a depolarization parameter or at least combined
arameter of both depolarization and repolarization, in all
ubjects tested, the incidence of increase in the peak J-point
mplitude at peak exercise was lower (37%) in our Brugada
atients. This is probably in part because only 9 (10%) of our
3 BrS patients had the SCN5A mutation. We could not
dentify significant differences in HRR, QRS duration, peak
-point amplitude (lead V2), and ST-segment amplitude (leads
1, V2, V3) at peak exercise between patients with and without
CN5A mutation (not shown), and that may be also due to the
mall number of BrS patients with SCN5A mutation.
isk stratification in BrS. Implantation of an ICD is a first
ine of therapy for secondary prevention in patients with BrS
ho exhibited previous history of VF. The American College
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ociety guidelines refer to BrS patients who have had syncope
s having Class IIa indication for ICD therapy (23). However,
here is still much room for argument with respect to treat-
ents for patients who have had only syncope, and for
symptomatic patients (24–28). Although inducibility of VF
uring EPS (25,26), family history of SCD (24), spontaneous
ype 1 ECG (25,27), and late potential (28) have been
roposed as predictors of cardiac events, the availability of these
ndexes remains controversial (7,29).
In the present study, a previous episode of VF (or aborted
ardiac arrest) was the strongest predictor of subsequent cardiac
vents, as in previous studies (7,30,31). Moreover, ST-segment
ugmentation at early recovery during exercise testing was a
ignificant and independent predictor of subsequent cardiac events
n the present study. The results suggested that parasympathetic
ctivity plays an important role in both ST-segment augmentation
nd subsequent cardiac events. As previously noted, it remains
linical, Laboratory, Electrocardiographic, and Electrophysiologic Cnd Long-Term F llow-Up of Groups 1 and 2 Brugada Syndr me PatTable 2 Clinical, Labo ato y, Electro ardiographic, and Electropand Long-Term Follow-Up of Groups 1 and 2 Brugada S
Characteristic
Clinical characteristics
Age at exercise testing, yrs
Men
Family history of SCD at age 45 yrs or Brugada syndrome
Documented AF
Documented VF before exercise testing
Syncope alone before exercise testing
Asymptomatic before exercise testing
Age at first cardiac event, yrs
ICD implantation
Laboratory characteristics
SCN5A mutation
Electrocardiographic characteristics
RR, ms
PR, ms
QRS, ms
QTc, ms
ST-segment amplitude (mV) at baseline
V1
V2
V3
Spontaneous coved-type ST-segment elevation in right precordial leads
Signal-averaged electrocardiogram
TfQRS, ms
Late potential
Premature ventricular complexes during exercise
Premature ventricular complexes at recovery
Electrophysiologic characteristics
AH interval, ms
HV interval, ms
Induction of VF
Follow-up
Cardiac events
Follow-up period, months
F  atrial fibrillation; ICD  implantable cardioverter-defibrillator; SCD  sudden cardiac death;nclear that the cause of ST-segment augmentation in our 34 satients was a result of more increased parasympathetic activity or
f more increased susceptibility of the patients to the increased
arasympathetic reactivation.
tudy limitations. First, BrS patients were confined to those
ho were hospitalized in our hospital for close investigation.
hat indicates these patients can be biased toward relatively
igh risk. Second, the present study is based on data from a
mall population of 93 patients; hence, it was not sufficient to
valuate the prognosis, and there also was a small number of
vents. Although we adopted a step-wise approach, the limited
umber of events can lessen the precision of the consequences
or multivariate Cox regression analysis.
onclusions
he presence of SCN5A mutation was a significant predic-
or of subsequent cardiac events by univariate Cox regres-
ion analysis. However, multivariate Cox regression analysis
cteristicslog c Characteristics
me Patients
Group 1 (n  34) Group 2 (n  59) p Value
42 11 48 15 NS
34 (100%) 57 (97%) NS
7 (21%) 16 (27%) NS
7 (21%) 12 (20%) NS
7 (21%) 15 (25%) NS
12 (35%) 23 (39%) NS
15 (44%) 21 (36%) NS
42 13 45 15 NS
25 (74%) 38 (64%) NS
6 (17%) 3 (5%) 0.048
951 170 953 140 NS
184 28 175 31 NS
98 14 98 17 NS
418 46 415 43 NS
0.14 0.09 0.16 0.12 NS
0.41 0.22 0.38 0.26 NS
0.22 0.13 0.19 0.14 NS
30 (88%) 43 (73%) NS
122 15 118 17 NS
28/34 (82%) 30/57 (53%) 0.004
8 (24%) 11 (19%) NS
10 (29%) 9 (15%) NS
107 24 98 27 NS
45 8 44 11 NS
26/31 (84%) 33/47 (70%) NS
15 (44%) 10 (17%) 0.004
74.1 42.2 76.5 36.4 NS
 total filtered QRS duration; VF  ventricular fibrillation; other abbreviations as in Table 1.haraientsysio
yndrohowed it was not a significant predictor of prognosis.
F
r
p
e
S
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equired to evaluate the significance of the index as a
redictor of subsequent cardiac events.
Figure 4 Kaplan-Meier Analysis of Cardiac Events During Follow
Kaplan-Meier analysis of (A) cardiac events during follow-up, depending on pattern
dence of previous episode of ventricular fibrillation (VF), (C) SCN5A mutation, and
significantly higher cardiac event rate than did group 2 Brugada patients (log-rank,
had significantly greater values for occurrence of subsequent cardiac events than
tively), whereas spontaneous coved-type ST-segment elevation in Brugada patients
elevation (p  0.068).
redictive Capabilities of Cardiac EventsTable 3 Predictive Capabilities of Cardiac Events
Positive, n
Previous episodes of VF 22 (24%
Augmentation of ST-segment elevation at early recovery phase 34 (37%
SCN5A mutation 9 (10%
Spontaneous coved-type ST-segment 72 (77%
Late potential 58/91 (64%
VF inducible in EPS 59/78 (76%
Family history of SCD or BrS 23 (25%rS  Brugada syndrome; CI  confidence interval; EPS  electrophysiologic study; HR  hazard ratio; oAs for BrS patients with only syncope, subsequent cardiac
vents occurred in 50% (6 of 12) patients who exhibited
T-segment augmentation at early recovery. Asymptomatic
sponse to ST-segment elevation during exercise test (groups 1 and 2), (B) inci-
ontaneous coved-type ST-segment elevation. Group 1 Brugada patients had a
.0029). Brugada patients with previous episodes of VF or with SCN5A mutation
tients without VF episodes or SCN5A mutation (p  0.0013, p  0.028, respec-
ot predict cardiac events compared with patients not having such ST-segment
Univariate Analysis Multivariate Analysis
HR (95% CI) p Value HR (95% CI) p Value
3.40 (1.54–7.53) 0.003 3.25 (1.43–7.37) 0.005
3.17 (1.42–7.09) 0.005 3.17 (1.37–7.33) 0.007
2.86 (1.07–7.66) 0.037
3.51 (0.83–14.9) 0.089
2.25 (0.84–5.99) 0.11
0.73 (0.30–1.75) 0.48
1.19 (0.47–3.02) 0.72-Up
s in re
(D) sp
p  0
did pa
did n(%)
)
)
)
)
)
)
)ther abbreviations as in Table 2.
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Exercise Test in Brugada Syndrome November 2, 2010:1576–84atients who had ST-segment augmentation at early recov-
ry had a higher incidence of cardiac events than patients
ho did not. These data suggested the potential utility of
xercise testing to predict cardiac events for patients with
rS who have had previous episodes of only syncope but not
F or who have had no symptoms.
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